Retrospective cohort study of 132 TZ PCa patients were included to further analyze the independent prognostic factors and the effect of TET2 on overall survival (OS) and biochemical recurrence-free survival (BRFS). This evidence concerns the gene TET2 and posterior cortical atrophy.